Steroid-Induced Bradycardia Following Epidural Injection
The sudden bradycardia is most likely caused by the corticosteroid component of the epidural injection, and acute management should include discontinuation of any additional steroid doses and administration of atropine 0.5-1 mg IV if the patient is symptomatic or hemodynamically compromised.
Most Likely Etiology
The temporal relationship between the lumbar epidural steroid injection and sudden bradycardia, combined with normal cardiac workup (ECG, troponin, echo), strongly suggests steroid-induced sinus bradycardia. This is a well-documented but underrecognized adverse effect of corticosteroid administration 1, 2, 3.
Key Supporting Evidence:
- Bradycardia has been reported with various steroid formulations (methylprednisolone, dexamethasone, hydrocortisone, prednisone) and routes (IV, oral, epidural) 1, 2, 3, 4
- The mechanism appears related to direct effects on cardiac conduction, though not fully understood 5
- Bradycardia typically develops within 24-48 hours of steroid administration and resolves upon discontinuation 1, 2, 3
- Normal troponin and echo effectively rule out acute coronary syndrome or structural cardiac pathology 6
Acute Management Algorithm
1. Assess Hemodynamic Status Immediately
- If symptomatic (dizziness, syncope, chest pain) or hemodynamically unstable:
2. If Atropine Ineffective or Patient at Low Risk for Ischemia
Consider second-line agents 7:
- Dopamine: 5-20 mcg/kg/min IV (start at 5 mcg/kg/min, increase by 5 mcg/kg/min every 2 minutes)
- Isoproterenol: 20-60 mcg IV bolus or 1-20 mcg/min infusion
- Epinephrine: 2-10 mcg/min IV
Critical caveat: Doses of dopamine >20 mcg/kg/min may cause vasoconstriction or arrhythmias; monitor for ischemic chest pain 7
3. Discontinue Steroid Exposure
- No additional steroid doses should be given
- Bradycardia is typically self-limited and resolves within 24-72 hours after steroid discontinuation 1, 2, 3
4. Continuous Cardiac Monitoring
- Place on telemetry to monitor for progression to higher-grade conduction blocks or pauses
- Serial ECGs if symptoms persist
- In rare cases, severe bradycardia with high-dose IV steroids has progressed to asystole 5
5. Consider Temporary Pacing Only If:
- Severe symptomatic bradycardia refractory to medical therapy
- Hemodynamically significant pauses
- Life-threatening ventricular arrhythmias mediated by bradycardia 7
Important Clinical Considerations
Why Atropine May Not Work Optimally Here:
Unlike neurogenic bradycardia (where atropine is ineffective, such as post-heart transplant 7, 8), steroid-induced bradycardia should respond to atropine as the vagal pathways remain intact. However, response may be incomplete 2, 3.
Risk Factors to Note:
- Underlying cardiac disease increases risk of severe complications 5
- Rapid infusion rates and high doses are associated with worse outcomes 5
- Concomitant use of beta-blockers or calcium channel blockers may exacerbate bradycardia
What NOT to Do:
- Do not pursue invasive electrophysiology studies at this stage—the diagnosis is clear from the clinical context 7
- Do not rush to permanent pacemaker placement—this is a reversible cause 1, 2, 3
- Avoid additional steroid doses even if the original indication persists
Prognosis
Steroid-induced bradycardia is completely reversible with discontinuation of the offending agent. Most cases resolve within 24-72 hours without permanent sequelae 1, 2, 3, 4. The normal troponin and echocardiogram confirm no myocardial injury has occurred.
Follow-up Recommendations:
- Continue telemetry monitoring until heart rate normalizes
- Document baseline ECG for future reference
- Consider alternative pain management strategies if additional interventions are needed
- Counsel patient about this adverse effect for future steroid exposures